200 related articles for article (PubMed ID: 9343943)
21. A combined NMR, MD and DFT conformational analysis of 9-O-acetyl sialic acid-containing GM3 ganglioside glycan and its 9-N-acetyl mimic.
Li W; Battistel MD; Reeves H; Oh L; Yu H; Chen X; Wang LP; Freedberg DI
Glycobiology; 2020 Sep; 30(10):787-801. PubMed ID: 32350512
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of ganglioside GM3 and analogs containing modified sialic acids and ceramides.
Kiso M; Hasegawa A
Methods Enzymol; 1994; 242():173-83. PubMed ID: 7891575
[No Abstract] [Full Text] [Related]
23. Specificities of limulin and wheat-germ agglutinin towards some derivatives of GM3 gangliosides.
Maget-Dana R; Veh RW; Sander M; Roche AC; Schauer R; Monsigny M
Eur J Biochem; 1981; 114(1):11-6. PubMed ID: 6894280
[TBL] [Abstract][Full Text] [Related]
24. Sialic acid and GM3 ganglioside expression in papillomavirus-associated urinary bladder tumours of cattle with chronic enzootic haematuria.
Roperto S; Borzacchiello G; Casellato R; Galati P; Russo V; Sonnino S; Roperto F
J Comp Pathol; 2007; 137(2-3):87-93. PubMed ID: 17624364
[TBL] [Abstract][Full Text] [Related]
25. Ganglioside GM3 sialidase activity in fibroblasts of normal individuals and of patients with sialidosis and mucolipidosis IV. Subcellular distribution and and some properties.
Lieser M; Harms E; Kern H; Bach G; Cantz M
Biochem J; 1989 May; 260(1):69-74. PubMed ID: 2775195
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of N-parinaroyl analogs of ganglioside GM3 and de-N-acetyl GM3. Interactions with the EGF receptor kinase.
Song W; Welti R; Hafner-Strauss S; Rintoul DA
Biochemistry; 1993 Aug; 32(33):8602-7. PubMed ID: 8395211
[TBL] [Abstract][Full Text] [Related]
27. Antigenicity of the carbohydrate moiety of ganglioside GM3 having 3-O-acetyl ceramide.
Daino T; Tsuchihashi K; Kashiwagi M; Yachida Y; Akino T; Gasa S
Glycoconj J; 1999 Jan; 16(1):39-43. PubMed ID: 10580649
[TBL] [Abstract][Full Text] [Related]
28. Infantile sialic acid storage disease: biochemical studies.
Berra B; Gornati R; Rapelli S; Gatti R; Mancini GM; Ciana G; Bembi B
Am J Med Genet; 1995 Jul; 58(1):24-31. PubMed ID: 7573152
[TBL] [Abstract][Full Text] [Related]
29. Mechanism for the negative regulation of cell proliferation by ganglioside GM3 in high glucose-treated glomerular mesangial cells.
Rho YI; Kwak DH; Lee S; Ahn SH; Baek SH; Song JH; Choo YK; Choi BK; Jung KY
Life Sci; 2004 May; 75(1):51-62. PubMed ID: 15102521
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of a glioma-related ganglioside, O-Ac GM3 having 3-O-Ac ceramide and its substrate property toward hydrolases.
Tsuchihashi K; Daino T; Akino T; Gasa S
J Lipid Res; 1996 Oct; 37(10):2136-44. PubMed ID: 8906591
[TBL] [Abstract][Full Text] [Related]
31. Cell growth arrest by sialic acid clusters in ganglioside GM3 mimetic polymers.
Uemura S; Feng F; Kume M; Yamada K; Kabayama K; Nishimura S; Igarashi Y; Inokuchi J
Glycobiology; 2007 Jun; 17(6):568-77. PubMed ID: 17317719
[TBL] [Abstract][Full Text] [Related]
32. Involvement of the acyl chain of ceramide in carbohydrate recognition by an anti-glycolipid monoclonal antibody: the case of an anti-melanoma antibody, M2590, to GM3-ganglioside.
Itonori S; Hidari K; Sanai Y; Taniguchi M; Nagai Y
Glycoconj J; 1989; 6(4):551-60. PubMed ID: 2535499
[TBL] [Abstract][Full Text] [Related]
33. Preparation of deacetyl-, lyso-, and deacetyl-lyso-GM(3) by selective alkaline hydrolysis of GM3 ganglioside.
Valiente O; Mauri L; Casellato R; Fernandez LE; Sonnino S
J Lipid Res; 2001 Aug; 42(8):1318-24. PubMed ID: 11483634
[TBL] [Abstract][Full Text] [Related]
34. Ganglioside GM3 inhibits the high glucose- and TGF-beta1-induced proliferation of rat glomerular mesangial cells.
Kwak DH; Lee S; Kim SJ; Ahn SH; Song JH; Choo YK; Choi BK; Jung KY
Life Sci; 2005 Sep; 77(20):2540-51. PubMed ID: 15939439
[TBL] [Abstract][Full Text] [Related]
35. Structural characterization of gangliosides isolated from mullet milt using electrospray ionization-tandem mass spectrometry.
Zhu J; Li YT; Li SC; Cole RB
Glycobiology; 1999 Oct; 9(10):985-93. PubMed ID: 10521534
[TBL] [Abstract][Full Text] [Related]
36. A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases.
Verheijen FW; Verbeek E; Aula N; Beerens CE; Havelaar AC; Joosse M; Peltonen L; Aula P; Galjaard H; van der Spek PJ; Mancini GM
Nat Genet; 1999 Dec; 23(4):462-5. PubMed ID: 10581036
[TBL] [Abstract][Full Text] [Related]
37. Rapid internalization of exogenous ganglioside GM3 and its metabolism to ceramide in human myelogenous leukemia HL-60 cells compared with control ganglioside GM1.
Nakamura M; Tsunoda A; Furukawa Y; Sakai T; Saito M
FEBS Lett; 1997 Jan; 400(3):350-4. PubMed ID: 9009229
[TBL] [Abstract][Full Text] [Related]
38. Biosynthesis of conjugatable saccharidic moieties of GM2 and GM3 gangliosides by engineered E. coli.
Fort S; Birikaki L; Dubois MP; Antoine T; Samain E; Driguez H
Chem Commun (Camb); 2005 May; (20):2558-60. PubMed ID: 15900325
[TBL] [Abstract][Full Text] [Related]
39. Role of cell surface GM3 ganglioside and sialic acid in the antitumor activity of a GM3-based vaccine in the murine B16 melanoma model.
Gabri MR; Ripoll GV; Alonso DF; Gómez DE
J Cancer Res Clin Oncol; 2002 Dec; 128(12):669-77. PubMed ID: 12474053
[TBL] [Abstract][Full Text] [Related]
40. Incorporation and localisation of ganglioside GM3 in human intimal atherosclerotic lesions.
Bobryshev YV; Lord RS; Golovanova NK; Gracheva EV; Zvezdina ND; Sadovskaya VL; Prokazova NV
Biochim Biophys Acta; 1997 Oct; 1361(3):287-94. PubMed ID: 9375803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]